Diabetes in pregnancy
Gestational or pre-existing diabetes
Overview
Either gestational diabetes (glucose intolerance first recognised in pregnancy) or pre-existing type 1/2 diabetes. Raises risks of macrosomia, shoulder dystocia, neonatal hypoglycaemia, pre-eclampsia and congenital anomaly (pre-existing).
Recognise
- Often asymptomatic — detected on screening (OGTT)
- Risk factors: BMI >30, previous macrosomia/GDM, family history, ethnicity, PCOS
- Complications: macrosomia, polyhydramnios, shoulder dystocia, neonatal hypoglycaemia
Red flags
- Poor glycaemic control; pre-existing diabetes with retinopathy/nephropathy; DKA
Differentials & how to tell them apart
Investigations
OGTT (75 g) at 24–28 weeks for risk factors (or earlier if previous GDM). Diagnostic thresholds: fasting ≥5.6 or 2-hour ≥7.8 mmol/L. HbA1c and retinal/renal screening in pre-existing diabetes.
Management
Diet/exercise → metformin → insulin (stepwise to glucose targets)
- 1Gestational: trial of diet and exercise first if fasting glucose <7.Gate: If glucose targets not met in 1–2 weeks → metformin; add/switch to insulin if still not met. Fasting ≥7 at diagnosis → start insulin immediately
- 2Pre-existing diabetes: optimise control pre-conception, 5 mg folic acid, stop teratogenic drugs (ACEi/statins), aspirin from 12 weeks, retinal/renal screening.
- 3Deliver by ~37–39 weeks depending on control; manage neonatal hypoglycaemia. GDM: postpartum OGTT/HbA1c (resolves but recurs).
Key points
Macrosomia → shoulder dystocia risk. Neonatal hypoglycaemia after delivery (fetal hyperinsulinaemia). GDM usually resolves postpartum but carries future type 2 risk — screen.
Monitor & prognosis
Glucose diaries, fetal growth (USS), pre-eclampsia; neonatal glucose.
Good with control; GDM resolves but predicts later T2DM.
Source: NICE NG3 (diabetes in pregnancy)